Excerpt from an investment thread:
"from our friends in Czech Republic (translation):
This message wouldn't probably be published in American MSM. So I'll
allow myself to make an excerpt from this articles in Czech: Here,
Here and Here.
The Czech company Biotest near from Prague got from Austria a testing
batch of the new flu vaccine for 2009 from the american company
Baxter. In february they have found that the vaccine was contaminated
by the H5N1 - Avian flu virus, which is on the list of the possible
biological weapons and is one of the most dangerous biological agents
on the Earth - with more than 60% death rate. All the testing animals
in Biotest were subsequently destroyed and all the workers in the
company were put in quarantine. Luckily nobody contracted the disease.
Subsequently the same problem of the Baxter vaccines contamination
with H5N1 was found in the laboratories in Slovenia, Austria and
Germany, which confirms that the source of the contagion was in fact
the Baxter vaccine, which could be very probable, because Baxter is
one of the companies, which are developing the vaccines against H5N1.
First the company Baxter was evoking the 'trade secret" and refused to
comment how the H5N1 virus got into the vaccines, but then, when it
was already clear that the source of the contagion is in fact the
Baxter vaccine, their representative then confirmed, that the
contaminated vaccine was produced by Baxter laboratories for the
company AVIR Greenhills and distributed by Austrian company Ortha. And
on the end he even said that the material sent to the Czech republic,
Austria, Slovenia and Germany was in fact a pure H5N1 sent by accident
- maybe to mask the previous assumption, that it was in fact an
ordinary flu vaccine, which was contaminated. If it was in fact the
pure H5N1 or contaminated vaccine is still not clear.
Already weeks all the sanitation officials kick around in all the
countries where the contaminated vaccine was found. Czech authorities
now will hopefully proceed with the prosecution against all companies
involved and of course the suit for criminal negligence and public
menace against Baxter is still on the table.
But was this just a criminal negligence or it was an attempt to
provoke pandemia using vaccination against flu to spread the disease -
as happened with the anti-B hepatitis vaccination with vaccines
containing the HIV virus in US? - and then cash for the vaccines
against H5N1 which Baxter develops? How could on Earth a virus as H5N1
come to the ordinary flu vaccines? Don't they follow even basic
precautions in the american pharma companies? - As they didn't in this
case here and even after they learned their medicals are contaminated
with HIV, they sold them to Europe and East. Am I just a paranoid or
is David Rivera right?
________________________________________ _________________
Hello everyone. I just commented on the story regarding Baxter's
"accidental" mix-up of H5N1 on the site Fierce Vaccines (found via
Google News), and my comments were deleted and closed within
approximately 40 minutes. There is obviously something criminal and
HIGH LEVEL going on here with Baxter. I will include both the contact
information of their executives as well as my own scientific
commentary regarding what I believe to be the public exposure of a
vast international biological weapons program, or if you prefer, an
international corporate criminal syndicate which intends to release
biological weapons upon the world population.
BAXTER EXECUTIVES :
You initially claimed "trade secrets" regarding the vaccine
contamination. Could you explain why Baxter initially attempted to
cover this up?
===============================
Amundson, Joy Ms. Joy A. Amundson is Baxter International Inc.'s
Corporate Vice President — President, BioScience, having served in
that capacity since August 2004. Prior to joining Baxter in August
2004, Ms. Amundson was a principal of Amundson Partners, Inc., a
healthcare-consulting firm, from 2001. From 1995 to 2001, she served
as a Senior Vice President of Abbott Laboratories.
Joy A Amundson
3800 N Lk Shore Dr #6A
Chicago, IL 60613
(312) 281-1508
Despite popular media claims to the contrary, coinfection of H5N1 and
H3N2 would _not_ produce simple reassortment. It would produce
complex in vivo recombination of many competing strains in the
infected host. Does Baxter agree with this assessment?
===============================
Arduini, Peter Mr. Peter J. Arduini is Baxter International Inc.'s
Corporate Vice President — President, Medication Delivery. Prior to
joining Baxter in March 2005, Mr. Arduini spent 15 years at GE
Healthcare in a variety of management roles for domestic and global
businesses, the most recent of which was global general manager of GE
Healthcare’s computerized axial tomography scan (CT) and functional
imaging business.
Peter J Arduini
1059 Warrington Rd
Deerfield, IL 60015
(847) 444-0056
Furthermore the complex coinfection of H5N1 and H3N2 in a human would
produce natural selection pressure for maximum virulence. Does Baxter
dispute this claim? If so, why? If not, please explain why on earth
would Baxter attempt to cover up an incident which may well have been
lethal to 99% of humanity?
===============================
Baughman, Michael Mr. Michael J. Baughman is Baxter International
Inc.'s Corporate Vice President and Controller, having served in that
capacity since May 2006. Mr. Baughman joined Baxter in 2003 as Vice
President of Corporate Audit and was appointed Controller in March
2005. Before joining Baxter, Mr. Baughman spent 16 years at
PricewaterhouseCoopers LLP, in roles of increasing responsibility,
which included audit partner and partner in the firm’s mergers and
acquisitions practice.
Michael J Baughman
779 Parker Ct
Geneva, IL 60134
(630) 208-8215
The book "Evolutionary Dynamics" suggest that viral coinfection
selects for both maximum virulence and infectivity. Does Baxter
dispute these mathematics? Considering this danger is well known among
virologists, can Baxter immediately explain the precise sequence of
events, including dates, times, and people involved, which led to
contamination in over 16 labs in three separate countries in Europe
with coinfected H5N1 and H3N2 material?
===============================
Gatling, James Mr. James Michael Gatling is Corporate Vice President
— Manufacturing of Baxter International Inc. having served in that
capacity since December 1996. Mr. Gatling is also responsible for the
environment, health and safety function.
James Gatling
3704 Lindsay Ln
Crystal Lake, IL 60014
(815) 356-6180
Is Baxter prepared to cooperate with all relevant authorities in the
multiple countries to publicly release the genetic sequences of the
contaminated material? Furthermore, what Clade was Baxter's H5N1
vaccine from? Clade 1? Clade 2? Clade 3? Other? Is part of the
reason Baxter is so eager to destroy the existing vaccine material
that executives are concerned the world will find out their 'custom'
H5N1 does not resemble the strains circulating in waterfowl?
===============================
Gavin, James James R. Gavin III, M.D., Ph.D. has served as a Director
of Baxter since 2003. Since September 2007, Dr. Gavin has been Chief
Executive Officer and Chief Medical Officer of Healing Our Village,
Inc., a corporation that specializes in targeted advocacy, training,
education, disease management and outreach for health care
professionals and minority communities. From March 2005 to September
2007, Dr. Gavin served as Executive Vice President for Clinical
Affairs at Healing Our Village. Dr. Gavin has served as Clinical
Professor of Medicine and Senior Advisor of Health Affairs at Emory
University since January 2005. From January 2006 to July 2007, Dr.
Gavin served as President and CEO of MicroIslet, Inc., a biotechnology
company focused on transplantation therapy for insulin treated
diabetics. From July 2002 to January 2005, Dr. Gavin was President of
the Morehouse School of Medicine and from 1991 to July 2002 he was
Senior Science Officer at Howard Hughes Medical Institute, a nonprofit
medical research organization. From 1987 to 1991, he was at the
University of Oklahoma Health Sciences Center as a Professor and as
Chief of the Diabetes Section and Acting Chief of the Section on
Endocrinology, Metabolism and Hypertension. Dr. Gavin also serves as a
director of Amylin Pharmaceuticals, Inc. and Nuvelo Inc.
James R Gavin
440 Beverly Pl
Lake Forest, IL 60045
Phone Unpublished
Can Baxter please disclose all financial and social connections it has
with the incoming Obama administration (as Baxter and its executives
are based near Chicago) and whether Baxter stood to benefit
financially from the outbreak of a pandemic through a contaminated
season influenza vaccine in late 2009? Does Treasury Sec Geithner
hold shares in Baxter? If so, how many shares?
===============================
Greisch, John Mr. John J. Greisch is Baxter International Inc.'s
Corporate Vice President — President, International, having served in
that capacity since May 2006. From June 2004 to May 2006, he served as
Corporate Vice President and Chief Financial Officer and from January
to June 2004, he was Corporate Vice President — President, BioScience.
Prior to that, Mr. Greisch served as Vice President of Finance and
Strategy for BioScience from May 2003 to January 2004 and as Vice
President of Finance for Renal from March 2002 until April 2003. Prior
to joining Baxter, he was President and Chief Executive Officer of
FleetPride Corporation, a distribution company, from 1998 until 2001.
John Greisch
2636 Chesapeake Ln
Northbrook, IL 60062
(847) 480-0852
John Greisch
1310 Wildwood Ln
Northbrook, IL 60062
(847) 480-0852
Baxter Director Gail Fosler has profoundly disturbing connections to
powerful organizations including the Council on Foreign Relations,
high-level Chinese CCP leadership, and the Federal Reserve Bank of New
York. The question is simple: Is Baxter involved in biological
weapons programs? Are any of these programs 'international' in
scope? If so , who is providing the funding? What is the nature and
intent of these programs? Are any of these programs part of the so-
called 'black budget'? That is , is Baxter involved in any "Special
Access Programs" , as defined by Congress? Are any of these 'waived'
"Special Access Programs"? Are any of these 'unacknowledged'
'waived' Special Access Programs (also known as 'black programs')?
===============================
Hellman, Peter Peter S. Hellman has served as a Director of Baxter
since March 2005. Mr. Hellman served as President and Chief Financial
and Administrative Officer of Nordson Corporation, a manufacturer of
systems that apply adhesives, sealants and coatings during
manufacturing operations, from March 2004 until his retirement in
January 2008. From February 2000 to March 2004, Mr. Hellman served as
Executive Vice President and Chief Financial and Administrative
Officer of Nordson Corporation. From 1989 to 1999, Mr. Hellman held
various positions with TRW Inc., the most recent of which were
President and Chief Operating Officer. Mr. Hellman also serves as a
director of Qwest Communications International Inc. and Owens-
Illinois, Inc.
Peter Hellman
630 W Oakdale Ave #2E
Chicago, IL 60657
(773) 857-5227
Can Baxter explain exactly how a Level 3 biological warfare pathogen
found its way into H3N2 material, regardless whether or not this
experimental vaccine material was 'intended' for eventual use in
humans or not. Is the contaminated H5N1 strain genetically
engineered? If so, by whom? Does the NS protein in Baxter's H5N1
material contain polymorphisms which suppress human interferon
production? Was Baxter's H5N1a full set of influenza genes? Or was it
just the hemaglutanin and neuraminidase? Did Baxter's H5N1 contain a
poly-basic cleavage site on the Hemaglutanin surface protein? Why were
the samples of experimental vaccine material not irradiated?
===============================
Lichtenstein, Susan Ms. Susan R. Lichtenstein is Corporate Vice
President and General Counsel of Baxter International Inc. Prior to
joining Baxter in April 2005, Ms. Lichtenstein was a partner with
McDermott Will & Emery. She joined the law firm after having served as
General Counsel to the Governor of Illinois from 2003 to 2004. Ms.
Lichtenstein served as Senior Vice President, General Counsel and
Corporate Secretary for Tellabs, Inc. from 2000 to 2002. From 1994 to
2000, Ms. Lichtenstein held several positions with Ameritech ...
________________________________________ _______________
Hello all! I have translations of the original Czech news articles.
Get on this! Baxter and WHO are trying to cover up their criminal
activities! The name of the Czech subcontractor to Avir Green Hills
is 'Biotest', located in the town of Konarovice in the Czech republic.
------
February 18, 2009
It is a business secret - company refuses to comment on mistake in
safeguarding deadly vaccination
European Medicines Agency (EMEA) is investigating Austrian branch of
American pharmaceutical company Baxter. It is after pharmacists from
Austrian Ortha sent vaccination preventing flu to the Czech Rep for
testing and this vaccination found to be infected with a deadly virus
of the bird flue (H5N1).
Czech newspaper MF DNES brought attention to this case and
consequently, related laws might get changed.
Michael Vit, a chief hygienist and advisor from Ministry of Health,
says: “Our goal is to obtain a prior documentation for each and every
vaccination or drug coming for testing here, proving to us that these
materials are not contaminated. Or, we need to be able to pre-test
them in our national laboratory. So far, it is not the case.”
Czech research company Biotest (in Konarovice town), testing this
critical vaccination on lab ferrets, was forced to end the testing
process after a week and to kill the infected animals. Researchers
(13) working with this vaccine got immediately a shot of anti-virus
Tamiflu and are under the supervision of hygienists. Luckily, the
researchers are not infected, says Michael Vit.
The testing was permitted by Czech Ministry of Industry and Trade, yet
this Ministry does not have any real control over it. In the future,
these circumstances should change. Newly, Ministry of Health and
National Drug Control Committee should supervise all the medical
testing and research. Austrian workers will have to explain to these
Czech agencies how could such a serious mistake possibly happen and
who is responsible for it.
Spokesman of American Baxter, Richard Tischler, revealed to MF Dnes
newspaper only limited amount of information. He said that the mistake
happened in the Austrian branch and that it was a procedural mistake.
Other than that, it is our business secret and I can’t talk about it.
However, I can assure you that we made steps to prevent similar
mistake from happening again in the future.
According to Tischler, this mistake happened only in a batch shipped
to Czech Biotest. Baxter is one of the six international companies
entitled to develop vaccination preventing flu. In Baxter labs, a
deadly virus of the bird flu is stored as well as vaccination, made by
the company, which should prevent the flu.
Biotest was supposed to test anti-flu vaccination that should serve
Europeans during the next flu season. The researchers admit that a
situation like this never happened in the Czech Rep yet. It is an
extraordinary situation which showed a gap in our legislature and we
were not ready for it, says Roman Prymula, chairman of Czech
vaccination society. We can’t pretend that nothing happen; it is a
major mistake. Some 60 years ago in the US, children have paid for the
similar mistake by getting polio. And later on, in Germany,
researchers had mishandled TBC vaccination, said Jiri Beran from
Center for vaccination and travel medicine.
translation of:
http://zpravy.idnes.cz/unik-viru-je-obchodni-tajemstvi-odmita-firma-k...
===========
Austrian bird flu came to the Czech Rep and Germany
March 4, 2009
Deadly virus of the bird flu suddenly appeared on several places in
Europe. According to MF Dnes newspaper, people from Austrian branch of
Baxter were testing “contaminated vaccine material” not only in a
Czech lab, but also in labs of two neighboring countries.
Vaccine material contaminated with the bird flu was tested not only in
Austria, but also in the Czech Rep, Germany and Slovenia. Everywhere,
the same problem was observed, said Michael Vit.
Not one laboratory had a clue about this. Last day in January,
Austrian pharmacists sent “by an accident” a virus for testing to four
different labs and this virus, for its dangerous character, is
actually listed as a possible biological weapon.
The Czech lab is actually under an investigation by National institute
for nuclear safety now. Neither the Czech, nor Austrian labs informed
the Institute about the incident. Baxter comp. itself had learned
about this contamination incident about six days later when infected
ferrets started to behave strangely.
We should be definitely informed; it is against the law, said Dana
Drabova, a chairperson of National institute for nuclear safety,
especially, if the virus of bird flue H5N1 belongs on a list of
dangerous materials. Biotest might face a penalty as high as five
millions of CZK if we prove that this mistake is on a Biotest’s side.
European medicine agency (EMEA) is tracking this incident as well.
Baxter refused accusations that company would be conducting testing on
people: “We were intended to send a clear virus of common flu for
testing to Czech Biotest; by an accident, we sent the virus of bird
flue. The testing material got mixed up, said Tischler. According to
him, the risk of the bird flu getting out of the labs was very low.
Specific process that was used during the production of this testing
material will be never used again.
translation of:
http://zpravy.idnes.cz/rakouska-ptaci-chripka-sla-do-ceska-i-nemecka-...
===========
Contaminated vaccination was tested not only in the Czech Rep
Prague
Vaccine material contaminated with the bird flu was tested not only in
Austria, but also in the Czech Rep, Germany and Slovenia. Everywhere,
the same problem was observed, said Michael Vit. None of the labs had
a clue about it.
Tischler, rep from Baxter, emphasized for Czech Press Agency, that the
material was produced solely for a research and never meant to be used
for any other purposes or used on human beings. According to Tichler,
this testing material was not sent by American Baxter, but by Austrian
AVIR Greenhills which also hired Czech Biotest.
Contamination itself happened during this one specific research
project for AVIR Greenhills in labs of Baxter company. And this
certain process will not be performed ever again, said Tischler.
Austrian institutions dealing with public health and safety approved
Baxter’s safety and prevention steps taken afterward, describing them
as adequate to this kind of situation.
According to Tischler, designated people did work with this
experimental material in isolated labs. Also, reps from Biotest said
that “this project was conducted under standard conditions - with a
high level of work safety, in isolated labs and with use of
appropriate protection tools. No researcher was infected”.
In the Austrian branch, representatives from EMEA started their
investigation.
translation of:
http://www.ceskenoviny.cz/zpravy/kontaminovana-vakcina-se-testovala-n...
________________________________________ _______________
________________________________________ _______________
Dear Mr. Jones,
thank you for your interest and the questions you forwarded to AVIR
Green Hills.
Please find below the comments of AVIR Green Hills with respect to
this issue.
"AVIR Green Hills is a Vienna-based biotechnology company doing
research, among other things, in new immunization technology.
Baxter was contracted to provide experimental influenza virus material
to AVIR Green Hills to be used for testing purposes. This material was
used for AVIR Green Hill's research with respect to the development of
an influenza vaccine. It was used for laboratory purposes only and not
for clinical use in humans.
The experimental material was handled at AVIR Green Hill`s own
facilities in Vienna and in three contracted laboratories in Slovenia,
Germany and the Czech Republic for research purposes and not for use
in humans. In all laboratories the material was used under controlled
biosafety conditions.
In the process of testing, it turned out that a quantity of this
material was possibly contaminated with the Avian influenza virus.
Work on the research was immediately suspended upon discovery of the
contamination. Immediate steps were taken to sanitize all impacted
laboratories and destroy any potentially contaminated virus samples.
As a precaution all laboratory employees, who had worked with the
material under rigorous laboratory conditions, underwent antiviral
treatment and were medically examined by specialists for signs of
potential infection. The results of all performed tests were
negative, during as well as after the incubation period.
All safety regulations were adhered to. The authorities were notified
as quickly as possible. At no time was there a danger to the
population or environment."
Kind regards
Birgit Kofler
--
Dr. Birgit Kofler-Bettschart
Media relations for AVIR Green Hills
A-1090 Wien, Liechtensteinstr. 46a/1/1/9
Tel.: +43-1-3194378-0
Fax: +43-1-3194378-20
E-Mail: kof...@bkkommunikation.com
________________________________________ ________________
Dear Dr. Kofler,
I have found your response extremely disappointing. Avir Green Hills
has evaded most all of my questions. Do not think this fact is lost
on myself, or those in the American independent media. I was told by
Dr. Joachim Seipelt over the phone that Avir Green Hills would respond
to all of my written questions regarding the H5N1 contamination.
Apparently, this was not true.
I will once again, for the record, submit my list of questions to Avir
Green Hills. I suggest you respond fully this time. It is in the
best interest of Avir Green Hills to set the record straight. Please
be aware , I will do my best to ensure both your previous 'non-
response' as well as my list of questions gets forwarded to the
appropriate authorities in the US Pentagon and National Insitutes of
Health, for potential investigation of criminal activity by Baxter and
Avir Green Hills. I will be putting together full documentation of
this incident.
If Avir Green Hills wishes to see themselves represented in my public
documentation, it would be in their best interest to respond to my
questions.
QUESTIONS TO AVIR GREEN HILLS
What specific Biological Safety Level (BSL) was Avir Green Hills
adhering to? Is Avir Green Hills a BSL3 facility? What are the
names of the subcontractors which were contaminated with H5N1? What
is the name of the official responsible for Biological Safety at Avir
Green Hills?
What exactly was the H3N2/H5N1 material that Baxter sent your lab
(vaccine, cell culture, RNA, etc)? When did you receive this material
from Baxter in Orth-Donau? Why did they send it to you? What did
Baxter claim this material was (seasonal H3N2?) What SPECIFIC
influenza strain did Baxter claim this material contained? Did your
company provide any modifications to the material? Did Avir Green
Hills test this material in animals? Did you assume the material your
received was irradiated (inactivated) by Baxter? Did Avir Green Hills
irradiate the material?
What was your companies purpose with this supposed H3N2 sent to you by
Baxter? For example, why did Baxter decide to use Avir Green Hills?
What was the exact purpose of this contract? Did Baxter ask you to
send it to subcontractors? Or was that the decision of Avir Green
Hills?
When did Avir Green hills first become aware the material Baxter
provided was contaminated with H5N1? How did Avir Green Hills become
aware that the H3N2 material contained H5N1? Was Avir Green Hills
alerted by the health authorities, or by Biotest?
What are the names of the labs? We also understand this material was
sent to laboratories in Austria, Czech Republic, Slovania, and
Germany. We know one of these labs was Biotest in Czech Republic.
Biotest is not returning phone calls or emails and thirteen of their
employees are in quarantine according to the Czech media. Two of the
Biotest executives are on "vacation". Can you provide us with any
further information regarding Biotest? Are all their employees still
alive? To your knowledge has any human contracted H5N1 from this
incident?
Are any members of Avir Green Hills under quarantine? Were employees
of Avir Green Hills under quarantine at any time since discovery of
the contamination?
What was the purpose of the labs to which Avir Green Hills sent
Baxter's contaminated material? Were these labs intended to test the
vaccine in animals? Or did Biotest accidently break the contract by
injecting the material into their ferrets? If they were not supposed
to inject the material into animals, what were these subcontractors
like Biotest supposed to do with the material?
Does Avir still have possession of any of the contaminated samples?
Or was it destroyed the EMEA? If destroyed, who destroyed the
samples, on what date did they destroy them, and why? Does Avir have
RNA sequences of the contaminated material? If so, is Avir prepered
to release the gene sequences of this contaminated material for the
interest of the public health? If not, is Avir prepared to either A)
sequence the material or B) send the material to a trusted third
party for which to determine the RNA sequences? What genetic Clade
was the H5N1 material from?
Sincerely,
Alexander S Jones
Washington DC
________________________________________ __
"from our friends in Czech Republic (translation):
This message wouldn't probably be published in American MSM. So I'll
allow myself to make an excerpt from this articles in Czech: Here,
Here and Here.
The Czech company Biotest near from Prague got from Austria a testing
batch of the new flu vaccine for 2009 from the american company
Baxter. In february they have found that the vaccine was contaminated
by the H5N1 - Avian flu virus, which is on the list of the possible
biological weapons and is one of the most dangerous biological agents
on the Earth - with more than 60% death rate. All the testing animals
in Biotest were subsequently destroyed and all the workers in the
company were put in quarantine. Luckily nobody contracted the disease.
Subsequently the same problem of the Baxter vaccines contamination
with H5N1 was found in the laboratories in Slovenia, Austria and
Germany, which confirms that the source of the contagion was in fact
the Baxter vaccine, which could be very probable, because Baxter is
one of the companies, which are developing the vaccines against H5N1.
First the company Baxter was evoking the 'trade secret" and refused to
comment how the H5N1 virus got into the vaccines, but then, when it
was already clear that the source of the contagion is in fact the
Baxter vaccine, their representative then confirmed, that the
contaminated vaccine was produced by Baxter laboratories for the
company AVIR Greenhills and distributed by Austrian company Ortha. And
on the end he even said that the material sent to the Czech republic,
Austria, Slovenia and Germany was in fact a pure H5N1 sent by accident
- maybe to mask the previous assumption, that it was in fact an
ordinary flu vaccine, which was contaminated. If it was in fact the
pure H5N1 or contaminated vaccine is still not clear.
Already weeks all the sanitation officials kick around in all the
countries where the contaminated vaccine was found. Czech authorities
now will hopefully proceed with the prosecution against all companies
involved and of course the suit for criminal negligence and public
menace against Baxter is still on the table.
But was this just a criminal negligence or it was an attempt to
provoke pandemia using vaccination against flu to spread the disease -
as happened with the anti-B hepatitis vaccination with vaccines
containing the HIV virus in US? - and then cash for the vaccines
against H5N1 which Baxter develops? How could on Earth a virus as H5N1
come to the ordinary flu vaccines? Don't they follow even basic
precautions in the american pharma companies? - As they didn't in this
case here and even after they learned their medicals are contaminated
with HIV, they sold them to Europe and East. Am I just a paranoid or
is David Rivera right?
________________________________________ _________________
Hello everyone. I just commented on the story regarding Baxter's
"accidental" mix-up of H5N1 on the site Fierce Vaccines (found via
Google News), and my comments were deleted and closed within
approximately 40 minutes. There is obviously something criminal and
HIGH LEVEL going on here with Baxter. I will include both the contact
information of their executives as well as my own scientific
commentary regarding what I believe to be the public exposure of a
vast international biological weapons program, or if you prefer, an
international corporate criminal syndicate which intends to release
biological weapons upon the world population.
BAXTER EXECUTIVES :
You initially claimed "trade secrets" regarding the vaccine
contamination. Could you explain why Baxter initially attempted to
cover this up?
===============================
Amundson, Joy Ms. Joy A. Amundson is Baxter International Inc.'s
Corporate Vice President — President, BioScience, having served in
that capacity since August 2004. Prior to joining Baxter in August
2004, Ms. Amundson was a principal of Amundson Partners, Inc., a
healthcare-consulting firm, from 2001. From 1995 to 2001, she served
as a Senior Vice President of Abbott Laboratories.
Joy A Amundson
3800 N Lk Shore Dr #6A
Chicago, IL 60613
(312) 281-1508
Despite popular media claims to the contrary, coinfection of H5N1 and
H3N2 would _not_ produce simple reassortment. It would produce
complex in vivo recombination of many competing strains in the
infected host. Does Baxter agree with this assessment?
===============================
Arduini, Peter Mr. Peter J. Arduini is Baxter International Inc.'s
Corporate Vice President — President, Medication Delivery. Prior to
joining Baxter in March 2005, Mr. Arduini spent 15 years at GE
Healthcare in a variety of management roles for domestic and global
businesses, the most recent of which was global general manager of GE
Healthcare’s computerized axial tomography scan (CT) and functional
imaging business.
Peter J Arduini
1059 Warrington Rd
Deerfield, IL 60015
(847) 444-0056
Furthermore the complex coinfection of H5N1 and H3N2 in a human would
produce natural selection pressure for maximum virulence. Does Baxter
dispute this claim? If so, why? If not, please explain why on earth
would Baxter attempt to cover up an incident which may well have been
lethal to 99% of humanity?
===============================
Baughman, Michael Mr. Michael J. Baughman is Baxter International
Inc.'s Corporate Vice President and Controller, having served in that
capacity since May 2006. Mr. Baughman joined Baxter in 2003 as Vice
President of Corporate Audit and was appointed Controller in March
2005. Before joining Baxter, Mr. Baughman spent 16 years at
PricewaterhouseCoopers LLP, in roles of increasing responsibility,
which included audit partner and partner in the firm’s mergers and
acquisitions practice.
Michael J Baughman
779 Parker Ct
Geneva, IL 60134
(630) 208-8215
The book "Evolutionary Dynamics" suggest that viral coinfection
selects for both maximum virulence and infectivity. Does Baxter
dispute these mathematics? Considering this danger is well known among
virologists, can Baxter immediately explain the precise sequence of
events, including dates, times, and people involved, which led to
contamination in over 16 labs in three separate countries in Europe
with coinfected H5N1 and H3N2 material?
===============================
Gatling, James Mr. James Michael Gatling is Corporate Vice President
— Manufacturing of Baxter International Inc. having served in that
capacity since December 1996. Mr. Gatling is also responsible for the
environment, health and safety function.
James Gatling
3704 Lindsay Ln
Crystal Lake, IL 60014
(815) 356-6180
Is Baxter prepared to cooperate with all relevant authorities in the
multiple countries to publicly release the genetic sequences of the
contaminated material? Furthermore, what Clade was Baxter's H5N1
vaccine from? Clade 1? Clade 2? Clade 3? Other? Is part of the
reason Baxter is so eager to destroy the existing vaccine material
that executives are concerned the world will find out their 'custom'
H5N1 does not resemble the strains circulating in waterfowl?
===============================
Gavin, James James R. Gavin III, M.D., Ph.D. has served as a Director
of Baxter since 2003. Since September 2007, Dr. Gavin has been Chief
Executive Officer and Chief Medical Officer of Healing Our Village,
Inc., a corporation that specializes in targeted advocacy, training,
education, disease management and outreach for health care
professionals and minority communities. From March 2005 to September
2007, Dr. Gavin served as Executive Vice President for Clinical
Affairs at Healing Our Village. Dr. Gavin has served as Clinical
Professor of Medicine and Senior Advisor of Health Affairs at Emory
University since January 2005. From January 2006 to July 2007, Dr.
Gavin served as President and CEO of MicroIslet, Inc., a biotechnology
company focused on transplantation therapy for insulin treated
diabetics. From July 2002 to January 2005, Dr. Gavin was President of
the Morehouse School of Medicine and from 1991 to July 2002 he was
Senior Science Officer at Howard Hughes Medical Institute, a nonprofit
medical research organization. From 1987 to 1991, he was at the
University of Oklahoma Health Sciences Center as a Professor and as
Chief of the Diabetes Section and Acting Chief of the Section on
Endocrinology, Metabolism and Hypertension. Dr. Gavin also serves as a
director of Amylin Pharmaceuticals, Inc. and Nuvelo Inc.
James R Gavin
440 Beverly Pl
Lake Forest, IL 60045
Phone Unpublished
Can Baxter please disclose all financial and social connections it has
with the incoming Obama administration (as Baxter and its executives
are based near Chicago) and whether Baxter stood to benefit
financially from the outbreak of a pandemic through a contaminated
season influenza vaccine in late 2009? Does Treasury Sec Geithner
hold shares in Baxter? If so, how many shares?
===============================
Greisch, John Mr. John J. Greisch is Baxter International Inc.'s
Corporate Vice President — President, International, having served in
that capacity since May 2006. From June 2004 to May 2006, he served as
Corporate Vice President and Chief Financial Officer and from January
to June 2004, he was Corporate Vice President — President, BioScience.
Prior to that, Mr. Greisch served as Vice President of Finance and
Strategy for BioScience from May 2003 to January 2004 and as Vice
President of Finance for Renal from March 2002 until April 2003. Prior
to joining Baxter, he was President and Chief Executive Officer of
FleetPride Corporation, a distribution company, from 1998 until 2001.
John Greisch
2636 Chesapeake Ln
Northbrook, IL 60062
(847) 480-0852
John Greisch
1310 Wildwood Ln
Northbrook, IL 60062
(847) 480-0852
Baxter Director Gail Fosler has profoundly disturbing connections to
powerful organizations including the Council on Foreign Relations,
high-level Chinese CCP leadership, and the Federal Reserve Bank of New
York. The question is simple: Is Baxter involved in biological
weapons programs? Are any of these programs 'international' in
scope? If so , who is providing the funding? What is the nature and
intent of these programs? Are any of these programs part of the so-
called 'black budget'? That is , is Baxter involved in any "Special
Access Programs" , as defined by Congress? Are any of these 'waived'
"Special Access Programs"? Are any of these 'unacknowledged'
'waived' Special Access Programs (also known as 'black programs')?
===============================
Hellman, Peter Peter S. Hellman has served as a Director of Baxter
since March 2005. Mr. Hellman served as President and Chief Financial
and Administrative Officer of Nordson Corporation, a manufacturer of
systems that apply adhesives, sealants and coatings during
manufacturing operations, from March 2004 until his retirement in
January 2008. From February 2000 to March 2004, Mr. Hellman served as
Executive Vice President and Chief Financial and Administrative
Officer of Nordson Corporation. From 1989 to 1999, Mr. Hellman held
various positions with TRW Inc., the most recent of which were
President and Chief Operating Officer. Mr. Hellman also serves as a
director of Qwest Communications International Inc. and Owens-
Illinois, Inc.
Peter Hellman
630 W Oakdale Ave #2E
Chicago, IL 60657
(773) 857-5227
Can Baxter explain exactly how a Level 3 biological warfare pathogen
found its way into H3N2 material, regardless whether or not this
experimental vaccine material was 'intended' for eventual use in
humans or not. Is the contaminated H5N1 strain genetically
engineered? If so, by whom? Does the NS protein in Baxter's H5N1
material contain polymorphisms which suppress human interferon
production? Was Baxter's H5N1a full set of influenza genes? Or was it
just the hemaglutanin and neuraminidase? Did Baxter's H5N1 contain a
poly-basic cleavage site on the Hemaglutanin surface protein? Why were
the samples of experimental vaccine material not irradiated?
===============================
Lichtenstein, Susan Ms. Susan R. Lichtenstein is Corporate Vice
President and General Counsel of Baxter International Inc. Prior to
joining Baxter in April 2005, Ms. Lichtenstein was a partner with
McDermott Will & Emery. She joined the law firm after having served as
General Counsel to the Governor of Illinois from 2003 to 2004. Ms.
Lichtenstein served as Senior Vice President, General Counsel and
Corporate Secretary for Tellabs, Inc. from 2000 to 2002. From 1994 to
2000, Ms. Lichtenstein held several positions with Ameritech ...
________________________________________ _______________
Hello all! I have translations of the original Czech news articles.
Get on this! Baxter and WHO are trying to cover up their criminal
activities! The name of the Czech subcontractor to Avir Green Hills
is 'Biotest', located in the town of Konarovice in the Czech republic.
------
February 18, 2009
It is a business secret - company refuses to comment on mistake in
safeguarding deadly vaccination
European Medicines Agency (EMEA) is investigating Austrian branch of
American pharmaceutical company Baxter. It is after pharmacists from
Austrian Ortha sent vaccination preventing flu to the Czech Rep for
testing and this vaccination found to be infected with a deadly virus
of the bird flue (H5N1).
Czech newspaper MF DNES brought attention to this case and
consequently, related laws might get changed.
Michael Vit, a chief hygienist and advisor from Ministry of Health,
says: “Our goal is to obtain a prior documentation for each and every
vaccination or drug coming for testing here, proving to us that these
materials are not contaminated. Or, we need to be able to pre-test
them in our national laboratory. So far, it is not the case.”
Czech research company Biotest (in Konarovice town), testing this
critical vaccination on lab ferrets, was forced to end the testing
process after a week and to kill the infected animals. Researchers
(13) working with this vaccine got immediately a shot of anti-virus
Tamiflu and are under the supervision of hygienists. Luckily, the
researchers are not infected, says Michael Vit.
The testing was permitted by Czech Ministry of Industry and Trade, yet
this Ministry does not have any real control over it. In the future,
these circumstances should change. Newly, Ministry of Health and
National Drug Control Committee should supervise all the medical
testing and research. Austrian workers will have to explain to these
Czech agencies how could such a serious mistake possibly happen and
who is responsible for it.
Spokesman of American Baxter, Richard Tischler, revealed to MF Dnes
newspaper only limited amount of information. He said that the mistake
happened in the Austrian branch and that it was a procedural mistake.
Other than that, it is our business secret and I can’t talk about it.
However, I can assure you that we made steps to prevent similar
mistake from happening again in the future.
According to Tischler, this mistake happened only in a batch shipped
to Czech Biotest. Baxter is one of the six international companies
entitled to develop vaccination preventing flu. In Baxter labs, a
deadly virus of the bird flu is stored as well as vaccination, made by
the company, which should prevent the flu.
Biotest was supposed to test anti-flu vaccination that should serve
Europeans during the next flu season. The researchers admit that a
situation like this never happened in the Czech Rep yet. It is an
extraordinary situation which showed a gap in our legislature and we
were not ready for it, says Roman Prymula, chairman of Czech
vaccination society. We can’t pretend that nothing happen; it is a
major mistake. Some 60 years ago in the US, children have paid for the
similar mistake by getting polio. And later on, in Germany,
researchers had mishandled TBC vaccination, said Jiri Beran from
Center for vaccination and travel medicine.
translation of:
http://zpravy.idnes.cz/unik-viru-je-obchodni-tajemstvi-odmita-firma-k...
===========
Austrian bird flu came to the Czech Rep and Germany
March 4, 2009
Deadly virus of the bird flu suddenly appeared on several places in
Europe. According to MF Dnes newspaper, people from Austrian branch of
Baxter were testing “contaminated vaccine material” not only in a
Czech lab, but also in labs of two neighboring countries.
Vaccine material contaminated with the bird flu was tested not only in
Austria, but also in the Czech Rep, Germany and Slovenia. Everywhere,
the same problem was observed, said Michael Vit.
Not one laboratory had a clue about this. Last day in January,
Austrian pharmacists sent “by an accident” a virus for testing to four
different labs and this virus, for its dangerous character, is
actually listed as a possible biological weapon.
The Czech lab is actually under an investigation by National institute
for nuclear safety now. Neither the Czech, nor Austrian labs informed
the Institute about the incident. Baxter comp. itself had learned
about this contamination incident about six days later when infected
ferrets started to behave strangely.
We should be definitely informed; it is against the law, said Dana
Drabova, a chairperson of National institute for nuclear safety,
especially, if the virus of bird flue H5N1 belongs on a list of
dangerous materials. Biotest might face a penalty as high as five
millions of CZK if we prove that this mistake is on a Biotest’s side.
European medicine agency (EMEA) is tracking this incident as well.
Baxter refused accusations that company would be conducting testing on
people: “We were intended to send a clear virus of common flu for
testing to Czech Biotest; by an accident, we sent the virus of bird
flue. The testing material got mixed up, said Tischler. According to
him, the risk of the bird flu getting out of the labs was very low.
Specific process that was used during the production of this testing
material will be never used again.
translation of:
http://zpravy.idnes.cz/rakouska-ptaci-chripka-sla-do-ceska-i-nemecka-...
===========
Contaminated vaccination was tested not only in the Czech Rep
Prague
Vaccine material contaminated with the bird flu was tested not only in
Austria, but also in the Czech Rep, Germany and Slovenia. Everywhere,
the same problem was observed, said Michael Vit. None of the labs had
a clue about it.
Tischler, rep from Baxter, emphasized for Czech Press Agency, that the
material was produced solely for a research and never meant to be used
for any other purposes or used on human beings. According to Tichler,
this testing material was not sent by American Baxter, but by Austrian
AVIR Greenhills which also hired Czech Biotest.
Contamination itself happened during this one specific research
project for AVIR Greenhills in labs of Baxter company. And this
certain process will not be performed ever again, said Tischler.
Austrian institutions dealing with public health and safety approved
Baxter’s safety and prevention steps taken afterward, describing them
as adequate to this kind of situation.
According to Tischler, designated people did work with this
experimental material in isolated labs. Also, reps from Biotest said
that “this project was conducted under standard conditions - with a
high level of work safety, in isolated labs and with use of
appropriate protection tools. No researcher was infected”.
In the Austrian branch, representatives from EMEA started their
investigation.
translation of:
http://www.ceskenoviny.cz/zpravy/kontaminovana-vakcina-se-testovala-n...
________________________________________ _______________
________________________________________ _______________
Dear Mr. Jones,
thank you for your interest and the questions you forwarded to AVIR
Green Hills.
Please find below the comments of AVIR Green Hills with respect to
this issue.
"AVIR Green Hills is a Vienna-based biotechnology company doing
research, among other things, in new immunization technology.
Baxter was contracted to provide experimental influenza virus material
to AVIR Green Hills to be used for testing purposes. This material was
used for AVIR Green Hill's research with respect to the development of
an influenza vaccine. It was used for laboratory purposes only and not
for clinical use in humans.
The experimental material was handled at AVIR Green Hill`s own
facilities in Vienna and in three contracted laboratories in Slovenia,
Germany and the Czech Republic for research purposes and not for use
in humans. In all laboratories the material was used under controlled
biosafety conditions.
In the process of testing, it turned out that a quantity of this
material was possibly contaminated with the Avian influenza virus.
Work on the research was immediately suspended upon discovery of the
contamination. Immediate steps were taken to sanitize all impacted
laboratories and destroy any potentially contaminated virus samples.
As a precaution all laboratory employees, who had worked with the
material under rigorous laboratory conditions, underwent antiviral
treatment and were medically examined by specialists for signs of
potential infection. The results of all performed tests were
negative, during as well as after the incubation period.
All safety regulations were adhered to. The authorities were notified
as quickly as possible. At no time was there a danger to the
population or environment."
Kind regards
Birgit Kofler
--
Dr. Birgit Kofler-Bettschart
Media relations for AVIR Green Hills
A-1090 Wien, Liechtensteinstr. 46a/1/1/9
Tel.: +43-1-3194378-0
Fax: +43-1-3194378-20
E-Mail: kof...@bkkommunikation.com
________________________________________ ________________
Dear Dr. Kofler,
I have found your response extremely disappointing. Avir Green Hills
has evaded most all of my questions. Do not think this fact is lost
on myself, or those in the American independent media. I was told by
Dr. Joachim Seipelt over the phone that Avir Green Hills would respond
to all of my written questions regarding the H5N1 contamination.
Apparently, this was not true.
I will once again, for the record, submit my list of questions to Avir
Green Hills. I suggest you respond fully this time. It is in the
best interest of Avir Green Hills to set the record straight. Please
be aware , I will do my best to ensure both your previous 'non-
response' as well as my list of questions gets forwarded to the
appropriate authorities in the US Pentagon and National Insitutes of
Health, for potential investigation of criminal activity by Baxter and
Avir Green Hills. I will be putting together full documentation of
this incident.
If Avir Green Hills wishes to see themselves represented in my public
documentation, it would be in their best interest to respond to my
questions.
QUESTIONS TO AVIR GREEN HILLS
What specific Biological Safety Level (BSL) was Avir Green Hills
adhering to? Is Avir Green Hills a BSL3 facility? What are the
names of the subcontractors which were contaminated with H5N1? What
is the name of the official responsible for Biological Safety at Avir
Green Hills?
What exactly was the H3N2/H5N1 material that Baxter sent your lab
(vaccine, cell culture, RNA, etc)? When did you receive this material
from Baxter in Orth-Donau? Why did they send it to you? What did
Baxter claim this material was (seasonal H3N2?) What SPECIFIC
influenza strain did Baxter claim this material contained? Did your
company provide any modifications to the material? Did Avir Green
Hills test this material in animals? Did you assume the material your
received was irradiated (inactivated) by Baxter? Did Avir Green Hills
irradiate the material?
What was your companies purpose with this supposed H3N2 sent to you by
Baxter? For example, why did Baxter decide to use Avir Green Hills?
What was the exact purpose of this contract? Did Baxter ask you to
send it to subcontractors? Or was that the decision of Avir Green
Hills?
When did Avir Green hills first become aware the material Baxter
provided was contaminated with H5N1? How did Avir Green Hills become
aware that the H3N2 material contained H5N1? Was Avir Green Hills
alerted by the health authorities, or by Biotest?
What are the names of the labs? We also understand this material was
sent to laboratories in Austria, Czech Republic, Slovania, and
Germany. We know one of these labs was Biotest in Czech Republic.
Biotest is not returning phone calls or emails and thirteen of their
employees are in quarantine according to the Czech media. Two of the
Biotest executives are on "vacation". Can you provide us with any
further information regarding Biotest? Are all their employees still
alive? To your knowledge has any human contracted H5N1 from this
incident?
Are any members of Avir Green Hills under quarantine? Were employees
of Avir Green Hills under quarantine at any time since discovery of
the contamination?
What was the purpose of the labs to which Avir Green Hills sent
Baxter's contaminated material? Were these labs intended to test the
vaccine in animals? Or did Biotest accidently break the contract by
injecting the material into their ferrets? If they were not supposed
to inject the material into animals, what were these subcontractors
like Biotest supposed to do with the material?
Does Avir still have possession of any of the contaminated samples?
Or was it destroyed the EMEA? If destroyed, who destroyed the
samples, on what date did they destroy them, and why? Does Avir have
RNA sequences of the contaminated material? If so, is Avir prepered
to release the gene sequences of this contaminated material for the
interest of the public health? If not, is Avir prepared to either A)
sequence the material or B) send the material to a trusted third
party for which to determine the RNA sequences? What genetic Clade
was the H5N1 material from?
Sincerely,
Alexander S Jones
Washington DC
________________________________________ __